Latest News

First trial to investigate magic mushrooms as a treatment for depression delayed by UK and EU regulations

The world?s first clinical trial to explore the use of the hallucinogenic ingredient in magic mushrooms to treat depression is being delayed due to the UK and EU rules on the use of illegal drugs in research.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Anti-stroke drug effective treatment for middle-ear infections, researchers say

  • Implantable micro-device to monitor oxygen in glioma to improve treatment outcomes

  • Study on neurogenesis in the olfactory bulb

  • Raising a glass to the holidays: Research finds extra alcohol sold, consumed on holidays

  • Human stem cell model reveals molecular cues critical to neurovascular unit formation

  • Scientists create mice with a major genetic cause of ALS, frontotemporal dementia

  • Blood test for Alzheimer's one step closer

  • Switching off brain circuit renders mice 'out of touch' with environment

  • Facebook status updates reveal low self-esteem and narcissism

  • Anticipating temptation may reduce unethical behavior, research finds

  •